We spoke to Quim Segalés, CReSA researcher, about collaborative research and Covid-19
In the last year, due to the SARS-CoV-2 coronavirus pandemic, we have seen an extraordinary advance in the development of a new vaccine. This common objective has led the academic world to carry out open research in close collaboration with private companies and, finally, several vaccines to come out. Do you think this can be an indicator of the potential that collaborative research can reach if sufficient is encouraged?
23/03/2021
